Cigna Group (NYSE:CI) Given New $297.00 Price Target at Leerink Partners

Cigna Group (NYSE:CI) had its price target upped by research analysts at Leerink Partners from $270.00 to $297.00 in a research note issued on Friday,MarketScreener reports. The firm currently has a “market perform” rating on the health services provider’s stock. Leerink Partners’ price objective points to a potential upside of 2.24% from the company’s current price.

Other analysts have also recently issued research reports about the stock. Guggenheim reissued a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a report on Monday. Wolfe Research reduced their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Robert W. Baird dropped their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, January 24th. Finally, Mizuho set a $325.00 price target on Cigna Group in a research note on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $323.16.

Cigna Group Stock Performance

NYSE CI opened at $290.48 on Friday. The stock has a fifty day simple moving average of $274.47 and a 200-day simple moving average of $283.96. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a market cap of $77.60 billion, a PE ratio of 12.73, a P/E/G ratio of 0.96 and a beta of 0.27. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the previous year, the company posted $6.64 EPS. Cigna Group’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Institutional Trading of Cigna Group

A number of hedge funds have recently added to or reduced their stakes in the business. Larson Financial Group LLC increased its position in Cigna Group by 39.7% during the 4th quarter. Larson Financial Group LLC now owns 4,068 shares of the health services provider’s stock worth $1,120,000 after purchasing an additional 1,157 shares in the last quarter. Aviance Capital Partners LLC grew its stake in Cigna Group by 2.0% during the fourth quarter. Aviance Capital Partners LLC now owns 19,760 shares of the health services provider’s stock worth $5,438,000 after buying an additional 384 shares during the period. Profund Advisors LLC increased its position in shares of Cigna Group by 26.1% in the fourth quarter. Profund Advisors LLC now owns 4,345 shares of the health services provider’s stock worth $1,196,000 after acquiring an additional 900 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Cigna Group by 13.2% in the 4th quarter. ProShare Advisors LLC now owns 54,247 shares of the health services provider’s stock valued at $14,930,000 after acquiring an additional 6,332 shares during the period. Finally, Stronghold Wealth Management L.L.C. acquired a new position in shares of Cigna Group during the 4th quarter valued at $258,000. 86.99% of the stock is owned by institutional investors and hedge funds.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 results beat expectations — Cigna reported adjusted Q4 EPS of $8.08 and revenue of $72.5B (both ahead of Street estimates), driven by Evernorth growth and higher specialty volumes; the strong quarter underpins the market rally. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Positive Sentiment: FTC settlement with Express Scripts removes regulatory uncertainty and commits to reforms (including measures to lower insulin costs) — investors appear to view this as a de‑risking event for the PBM unit. Cigna settles FTC insulin case, commits overhauling drug pricing
• Positive Sentiment: Dividend increase — the board raised the quarterly payout to $1.56 (a ~3.3% raise), supporting income investors and signaling confidence in cash flow. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Positive Sentiment: Solid full‑year results — 2025 net income roughly $6B and double‑digit revenue growth highlight operational momentum across businesses. Cigna posts US$6 billion profit on double‑digit 2025 revenue growth
• Neutral Sentiment: Company set FY‑2026 EPS target of at least $30.25 — management established an outlook but it is a baseline that leaves room for variability given cost dynamics. The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend
• Neutral Sentiment: Analysts growing cautious on near‑term growth and valuation despite the beat — some coverage flags a tighter multiple if cost pressures persist. A Look At Cigna Group (CI) Valuation As Analysts Turn Cautious On Near Term Growth
• Negative Sentiment: Guidance and cost headwinds — Reuters and others note Cigna’s 2026 forecast came in below some Street expectations and management flagged continued medical cost and margin pressure, which could cap upside. Cigna 2026 forecast misses Wall Street expectations
• Negative Sentiment: Operational headwinds — elevated costs and fewer medical customers were noted as offsets to growth, which investors will watch in coming quarters. Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.